Dr. Reddy's Laboratories, Incorporated

Upsher Smith Laboratories, Inc.

Tonix Medicines, Inc.

Anil N Namboodiripad

Rajeev Singh Raghuvanshi

Piyush Gupta

Rajesh Ramesh Patil

Prabhu Prabhakara

Rajesh Kumar

Adam M Shain

The present application relates to a method of treating migraine or cluster headache in a human patient, said method comprising administering subcutaneously composition comprising sumatriptan or its pharmaceutically acceptable salt, in an amount equivalent to 3 mg sumatriptan base.

Pharmaceutical composition for treating migraine

An auto-injector device for administering a liquid pharmaceutical composition, in which an end-user can select between doses that the device is capable of delivering. The end-user choices that translate into the selected doses can be based on end-user perceived severity of symptoms, end-user weight and other such factors. In some embodiments the auto-injector is configured to administer the one chosen dose only. In other embodiments, the auto-injector can deliver second and subsequent doses up to full dose of the pharmaceutical composition disposed in the injector. The auto-injector can provide visual, audio, and tactile feedback, alone or in combination, to the user to indicate the dose selected, instructions for use, and when the dose has been administered.

Selectable single dose auto-injector and methods of making and using same

Growing community of inventors

Yardley, PA, United States of America

Anil N Namboodiripad